CervoMed Inc. (CRVO)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$4.0M$9.7M$7.1M$0$71,667$374,542$570,476$40,189
Gross profit$71,667$138,739−$1.7M−$170,204
Research & development$21.8M$18.8M$8.4M$1.3M$8.5M$9.4M$6.6M$5.8M$5.1M$7.3M$3.9M$2.9M$342,916
Operating expenses$32.3M$28.0M$15.0M$3.5M$23.8M$14.6M$12.8M$11.9M$14.7M$7.5M
Operating income−$28.3M−$18.2M−$7.8M−$3.5M−$24.7M−$16.0M−$11.6M−$19.0M−$11.3M−$18.4M−$6.4M−$14.6M−$12.8M−$11.8M−$16.4M−$7.6M
EBITDAderived−$3.5M−$24.6M−$15.9M−$6.4M−$14.0M−$12.7M−$11.6M−$16.4M−$7.6M
Net income−$27.0M−$16.3M−$2.2M−$5.8M−$24.1M−$14.2M−$11.8M−$18.4M−$1.4M−$18.0M−$6.7M−$14.4M−$2.5M−$6.9M−$22.6M−$8.4M
Basic EPSper diluted share-$2.98-$2.02-$0.82-$11.20-$12.38-$0.30-$1.76-$8.21-$3.16-$1.76-$2.56-$1.00-$1.00-$8.16-$0.26-$0.14
Diluted EPSper diluted share$2,038,891.00$1,946,859.00$53,831,973.00$6,706,509.00$3,242,301.00-$29.11-$1.76-$2.56-$1.00-$1.00-$8.16-$0.26-$0.14

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys23$3.79M disclosed value
Sells (SEC code S)0$0.00 disclosed value
23 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 11, 2026Form 4BOGER JOSHUA SDirector,TenPercentOwnerBuyCommon Stock · indirect955.4K$3.14$3.00M1.80M
Jun 11, 2026Form 4BOGER JOSHUA SDirector,TenPercentOwnerBuySeries C Warrants · derivative · indirect955.4K955.4K
Jun 11, 2026Form 4BOGER JOSHUA SDirector,TenPercentOwnerBuySeries B Warrants · derivative · indirect955.4K955.4K
Nov 18, 2025Form 4Winton MatthewChief Commercial and BusinessBuyCommon Stock1.5K$7.95$11.9K15.0K
Nov 18, 2025Form 4ELDER WILLIAM ROBERTCFO, GC & SecretaryBuyCommon Stock2.5K$8.32$20.8K12.5K